Purchasing Pharmaceuticals

The overall aim of this paper is to contribute to the understanding of Resource Allocation and Purchasing (RAP) arrangements as regards pharmaceuticals in developing countries. The specific objective of this paper is to examine the strategic questi...

Full description

Bibliographic Details
Main Authors:	Enemark, Ulrika, Alban, Anita, Vazquez, Enrique C.S.
Format:	Working Paper
Language:	English en_US
Published:	World Bank, Washington, DC 2013
Subjects:	ACCESS TO PHARMACEUTICALS ACCOUNTABILITY ALLOCATIVE EFFICIENCY ANTIBIOTICS BASIC HEALTH BUDGETING CHRONIC DISEASES CLINICS COMMON COLD COMMUNITY DRUG SCHEMES COST EFFECTIVENESS COST EFFECTIVENESS ANALYSIS COST SHARING COST SHIFTING DELIVERY SYSTEMS DEVELOPING COUNTRIES DIABETES DISTRIBUTION OF PHARMACEUTICALS DRUG FINANCING DRUG POLICY DRUG RESISTANCE DRUG THERAPY DRUGS ECONOMIC IMPACTS ECONOMIC INCENTIVES ECONOMIC STATUS EMPLOYMENT EPIDEMIOLOGY ESSENTIAL DRUGS EXTERNALITIES FINANCIAL MANAGEMENT FIXED COSTS FRAUD GENERIC DRUGS GONORRHEA HEALTH CARE HEALTH CARE EXPENDITURES HEALTH CARE FINANCING HEALTH CARE PROFESSIONALS HEALTH CARE SECTOR HEALTH EXPENDITURES HEALTH FACILITIES HEALTH FINANCE HEALTH INSURANCE HEALTH NEEDS HEALTH OUTCOMES HEALTH SECTOR HEALTH SERVICES HEALTH STATUS HEALTH SYSTEM HEALTH SYSTEMS HOSPITAL CARE HOSPITALS HOUSEHOLDS HUMAN DEVELOPMENT HUMAN RESOURCES IMMUNIZATION IMMUNIZATION SERVICES INCOME INFORMATION SYSTEMS INTELLECTUAL PROPERTY RIGHTS IRRATIONAL USE LESSONS LEARNED LOCAL HEALTH CENTERS MEDICAL EQUIPMENT MEDICAL STORES MEDICAL TREATMENT MEDICATION MEDICINE MEDICINES MORAL HAZARD MOTIVATION NATIONAL HEALTH INSURANCE NEGATIVE EFFECTS NUTRITION PATENTED DRUGS PATIENTS PHARMACEUTICAL POLICY PHARMACEUTICAL SECTOR PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOECONOMICS PHARMACY PRESCRIPTIONS PREVENTIVE HEALTH SERVICES PRIVATE PHARMACIES PRIVATE SECTOR PROCUREMENT PROMOTING HEALTH PUBLIC HEALTH PUBLIC SECTOR PURCHASING QUALITY CONTROL QUALITY OF CARE RATIONAL DRUG USE RATIONAL USE OF DRUGS RESOURCE ALLOCATION RURAL HOUSEHOLDS SCARCE RESOURCES SELF CARE SERVICE DELIVERY SOCIAL MEDICINE TARGET GROUPS THERAPIES TRANSPORT COSTS
Online Access:	http://documents.worldbank.org/curated/en/2004/09/5587363/purchasing-pharmaceuticals http://hdl.handle.net/10986/13705

id	okr-10986-13705
recordtype	oai_dc
spelling	okr-10986-137052021-04-23T14:03:09Z Purchasing Pharmaceuticals Enemark, Ulrika Alban, Anita Vazquez, Enrique C.S. ACCESS TO PHARMACEUTICALS ACCOUNTABILITY ALLOCATIVE EFFICIENCY ANTIBIOTICS BASIC HEALTH BUDGETING CHRONIC DISEASES CLINICS COMMON COLD COMMUNITY DRUG SCHEMES COST EFFECTIVENESS COST EFFECTIVENESS ANALYSIS COST SHARING COST SHIFTING DELIVERY SYSTEMS DEVELOPING COUNTRIES DIABETES DISTRIBUTION OF PHARMACEUTICALS DRUG FINANCING DRUG POLICY DRUG RESISTANCE DRUG THERAPY DRUGS ECONOMIC IMPACTS ECONOMIC INCENTIVES ECONOMIC STATUS EMPLOYMENT EPIDEMIOLOGY ESSENTIAL DRUGS EXTERNALITIES FINANCIAL MANAGEMENT FIXED COSTS FRAUD GENERIC DRUGS GONORRHEA HEALTH CARE HEALTH CARE EXPENDITURES HEALTH CARE FINANCING HEALTH CARE PROFESSIONALS HEALTH CARE SECTOR HEALTH EXPENDITURES HEALTH FACILITIES HEALTH FINANCE HEALTH INSURANCE HEALTH NEEDS HEALTH OUTCOMES HEALTH SECTOR HEALTH SERVICES HEALTH STATUS HEALTH SYSTEM HEALTH SYSTEMS HOSPITAL CARE HOSPITALS HOUSEHOLDS HUMAN DEVELOPMENT HUMAN RESOURCES IMMUNIZATION IMMUNIZATION SERVICES INCOME INFORMATION SYSTEMS INTELLECTUAL PROPERTY RIGHTS IRRATIONAL USE LESSONS LEARNED LOCAL HEALTH CENTERS MEDICAL EQUIPMENT MEDICAL STORES MEDICAL TREATMENT MEDICATION MEDICINE MEDICINES MORAL HAZARD MOTIVATION NATIONAL HEALTH INSURANCE NEGATIVE EFFECTS NUTRITION PATENTED DRUGS PATIENTS PHARMACEUTICAL POLICY PHARMACEUTICAL SECTOR PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOECONOMICS PHARMACY PRESCRIPTIONS PREVENTIVE HEALTH SERVICES PRIVATE PHARMACIES PRIVATE SECTOR PROCUREMENT PROMOTING HEALTH PUBLIC HEALTH PUBLIC SECTOR PURCHASING QUALITY CONTROL QUALITY OF CARE RATIONAL DRUG USE RATIONAL USE OF DRUGS RESOURCE ALLOCATION RURAL HOUSEHOLDS SCARCE RESOURCES SELF CARE SERVICE DELIVERY SOCIAL MEDICINE TARGET GROUPS THERAPIES TRANSPORT COSTS The overall aim of this paper is to contribute to the understanding of Resource Allocation and Purchasing (RAP) arrangements as regards pharmaceuticals in developing countries. The specific objective of this paper is to examine the strategic questions that arise, when pursuing an active purchasing and resource allocation strategy for drugs, as well as the actual practice and experience from applying different RAP strategies to promote access of the poor to essential drugs, i.e. availability of affordable essential drugs of good quality and appropriate and efficient use of drugs. 2013-05-30T18:22:59Z 2013-05-30T18:22:59Z 2004-09 http://documents.worldbank.org/curated/en/2004/09/5587363/purchasing-pharmaceuticals http://hdl.handle.net/10986/13705 English en_US Health, Nutrition and Population (HNP) discussion paper; CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Working Paper Publications & Research
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English en_US
topic	ACCESS TO PHARMACEUTICALS ACCOUNTABILITY ALLOCATIVE EFFICIENCY ANTIBIOTICS BASIC HEALTH BUDGETING CHRONIC DISEASES CLINICS COMMON COLD COMMUNITY DRUG SCHEMES COST EFFECTIVENESS COST EFFECTIVENESS ANALYSIS COST SHARING COST SHIFTING DELIVERY SYSTEMS DEVELOPING COUNTRIES DIABETES DISTRIBUTION OF PHARMACEUTICALS DRUG FINANCING DRUG POLICY DRUG RESISTANCE DRUG THERAPY DRUGS ECONOMIC IMPACTS ECONOMIC INCENTIVES ECONOMIC STATUS EMPLOYMENT EPIDEMIOLOGY ESSENTIAL DRUGS EXTERNALITIES FINANCIAL MANAGEMENT FIXED COSTS FRAUD GENERIC DRUGS GONORRHEA HEALTH CARE HEALTH CARE EXPENDITURES HEALTH CARE FINANCING HEALTH CARE PROFESSIONALS HEALTH CARE SECTOR HEALTH EXPENDITURES HEALTH FACILITIES HEALTH FINANCE HEALTH INSURANCE HEALTH NEEDS HEALTH OUTCOMES HEALTH SECTOR HEALTH SERVICES HEALTH STATUS HEALTH SYSTEM HEALTH SYSTEMS HOSPITAL CARE HOSPITALS HOUSEHOLDS HUMAN DEVELOPMENT HUMAN RESOURCES IMMUNIZATION IMMUNIZATION SERVICES INCOME INFORMATION SYSTEMS INTELLECTUAL PROPERTY RIGHTS IRRATIONAL USE LESSONS LEARNED LOCAL HEALTH CENTERS MEDICAL EQUIPMENT MEDICAL STORES MEDICAL TREATMENT MEDICATION MEDICINE MEDICINES MORAL HAZARD MOTIVATION NATIONAL HEALTH INSURANCE NEGATIVE EFFECTS NUTRITION PATENTED DRUGS PATIENTS PHARMACEUTICAL POLICY PHARMACEUTICAL SECTOR PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOECONOMICS PHARMACY PRESCRIPTIONS PREVENTIVE HEALTH SERVICES PRIVATE PHARMACIES PRIVATE SECTOR PROCUREMENT PROMOTING HEALTH PUBLIC HEALTH PUBLIC SECTOR PURCHASING QUALITY CONTROL QUALITY OF CARE RATIONAL DRUG USE RATIONAL USE OF DRUGS RESOURCE ALLOCATION RURAL HOUSEHOLDS SCARCE RESOURCES SELF CARE SERVICE DELIVERY SOCIAL MEDICINE TARGET GROUPS THERAPIES TRANSPORT COSTS
spellingShingle	ACCESS TO PHARMACEUTICALS ACCOUNTABILITY ALLOCATIVE EFFICIENCY ANTIBIOTICS BASIC HEALTH BUDGETING CHRONIC DISEASES CLINICS COMMON COLD COMMUNITY DRUG SCHEMES COST EFFECTIVENESS COST EFFECTIVENESS ANALYSIS COST SHARING COST SHIFTING DELIVERY SYSTEMS DEVELOPING COUNTRIES DIABETES DISTRIBUTION OF PHARMACEUTICALS DRUG FINANCING DRUG POLICY DRUG RESISTANCE DRUG THERAPY DRUGS ECONOMIC IMPACTS ECONOMIC INCENTIVES ECONOMIC STATUS EMPLOYMENT EPIDEMIOLOGY ESSENTIAL DRUGS EXTERNALITIES FINANCIAL MANAGEMENT FIXED COSTS FRAUD GENERIC DRUGS GONORRHEA HEALTH CARE HEALTH CARE EXPENDITURES HEALTH CARE FINANCING HEALTH CARE PROFESSIONALS HEALTH CARE SECTOR HEALTH EXPENDITURES HEALTH FACILITIES HEALTH FINANCE HEALTH INSURANCE HEALTH NEEDS HEALTH OUTCOMES HEALTH SECTOR HEALTH SERVICES HEALTH STATUS HEALTH SYSTEM HEALTH SYSTEMS HOSPITAL CARE HOSPITALS HOUSEHOLDS HUMAN DEVELOPMENT HUMAN RESOURCES IMMUNIZATION IMMUNIZATION SERVICES INCOME INFORMATION SYSTEMS INTELLECTUAL PROPERTY RIGHTS IRRATIONAL USE LESSONS LEARNED LOCAL HEALTH CENTERS MEDICAL EQUIPMENT MEDICAL STORES MEDICAL TREATMENT MEDICATION MEDICINE MEDICINES MORAL HAZARD MOTIVATION NATIONAL HEALTH INSURANCE NEGATIVE EFFECTS NUTRITION PATENTED DRUGS PATIENTS PHARMACEUTICAL POLICY PHARMACEUTICAL SECTOR PHARMACEUTICALS PHARMACIES PHARMACISTS PHARMACOECONOMICS PHARMACY PRESCRIPTIONS PREVENTIVE HEALTH SERVICES PRIVATE PHARMACIES PRIVATE SECTOR PROCUREMENT PROMOTING HEALTH PUBLIC HEALTH PUBLIC SECTOR PURCHASING QUALITY CONTROL QUALITY OF CARE RATIONAL DRUG USE RATIONAL USE OF DRUGS RESOURCE ALLOCATION RURAL HOUSEHOLDS SCARCE RESOURCES SELF CARE SERVICE DELIVERY SOCIAL MEDICINE TARGET GROUPS THERAPIES TRANSPORT COSTS Enemark, Ulrika Alban, Anita Vazquez, Enrique C.S. Purchasing Pharmaceuticals
relation	Health, Nutrition and Population (HNP) discussion paper;
description	The overall aim of this paper is to contribute to the understanding of Resource Allocation and Purchasing (RAP) arrangements as regards pharmaceuticals in developing countries. The specific objective of this paper is to examine the strategic questions that arise, when pursuing an active purchasing and resource allocation strategy for drugs, as well as the actual practice and experience from applying different RAP strategies to promote access of the poor to essential drugs, i.e. availability of affordable essential drugs of good quality and appropriate and efficient use of drugs.
format	Publications & Research :: Working Paper
author	Enemark, Ulrika Alban, Anita Vazquez, Enrique C.S.
author_facet	Enemark, Ulrika Alban, Anita Vazquez, Enrique C.S.
author_sort	Enemark, Ulrika
title	Purchasing Pharmaceuticals
title_short	Purchasing Pharmaceuticals
title_full	Purchasing Pharmaceuticals
title_fullStr	Purchasing Pharmaceuticals
title_full_unstemmed	Purchasing Pharmaceuticals
title_sort	purchasing pharmaceuticals
publisher	World Bank, Washington, DC
publishDate	2013
url	http://documents.worldbank.org/curated/en/2004/09/5587363/purchasing-pharmaceuticals http://hdl.handle.net/10986/13705
_version_	1764424204798656512

Purchasing Pharmaceuticals

Similar Items